Waterland-backed imc group progresses ambitious growth strategy with the addition of Indigo Medical
Medical compliance and technical review capability strengthen imc group’s offering
London, 13th April 2021
Indigo Medical, a leading provider of material review, medical signatory approval services and medical communication for global pharmaceutical and biopharma companies, is joining imc group with the backing of pan-European investor Waterland Private Equity. The new partnership enhances imc group’s increasing geographic footprint and capabilities, as well as disrupts the global healthcare communications industry with a one-stop service for clients across seven core divisions: Medical & Scientific Content, Publications, Digital & Creative, Insights & Consulting, Patient Engagement, Meetings & Events, and Medical Compliance & Material Review.
Established by pharmaceutical industry veterans, Tina and Rak Patel, Indigo Medical’s highly specialist knowledge in the areas of pharmaceutical material and marketing review, approval process management, and commercial compliance remains crucial to safely developing and bringing to market the latest treatments and therapies. Ensuring the highest standards of business conduct and integrity, the compliance function will be established as a separate entity – Indigo Medical Compliance – to impartially serve the needs of clients.
The financial terms of the transaction are not disclosed.
Co-founder and Director of Indigo Medical’s compliance and approval services Rak Patel commented,
“Our partnership will ensure that more clients can benefit from our many years of experience in providing sector-leading compliance services, simplifying the burden of copy review and approval, and enabling the faster deployment of healthcare solutions.”
Co-founder and Director of Indigo Medical’s communication services Tina Patel stated
“Our vision has always been to differentiate our services through world-class scientific know-how and client service. We are delighted to have found, in imc group, an organisation that not only shares this philosophy but enables us to expand our geographic footprint, providing a best-in-class service to our clients.”
President and CEO of imc group, Shairose Ebrahim, said,
“I am thrilled to welcome Rak, Tina and their team to imc group. This collaboration means that not only can we provide cutting-edge, end-to-end omnichannel and insights-led solutions to clients aimed at improving patient outcomes, but we can now also provide industry leading compliance and medical expertise which is ultimately about patient safety. I look forward to supporting Indigo Medical in the expansion of its capabilities globally.”
Waterland Private Equity Investment Director, Dominic Graham added,
“We are pleased to support Shairose and imc group as they continue their expansion through organic growth and acquisitions. The addition of the team at Indigo Medical not only adds valuable expertise and in-demand complementary services to imc group, but they also share the same ambition to shape the future of global healthcare communications.”
• imc group, Shairose Ebrahim, firstname.lastname@example.org
• Indigo Medical, Tina Patel, email@example.com
• Indigo Medical Compliance, Rak Patel, firstname.lastname@example.org
• James Isola, Maitland, email@example.com +44 (0) 7841 982 020
• Alasdair Lennon, Maitland, firstname.lastname@example.org +44 (0) 7342 704 229
About imc group
imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers and patients through transformative end-to-end solutions, scientific rigour, insights, and medical excellence. imc group offers its client partners a full range of omnichannel, insights and medical compliance services that span the entire drug life cycle and all therapeutic areas. With a geographic footprint in Europe, Canada, USA and MEA, and a client list comprised of many leading pharmaceutical, biopharma and diagnostic companies, the group provides a boutique approach to delivery and customises strategies that address with precision, the needs of each client.
More information: www.imcmedcom.com
About Indigo Medical
Indigo Medical is a leading provider of medical and technical review, nominated signatory content certification, referencing, compliance, system agnostic content upload expertise and medical communication services to the pharmaceutical industry. With offices in the UK, the company was founded in 2014 by Tina Patel and Dr Rak Patel, and employs physicians, pharmacists and PhDs who are highly proficient in effectively navigating the copy review and approval process as well as delivering stand-out medical communication programmes. Indigo Medical is a trusted partner to many pharmaceutical companies and its trailblazing medical review process facilitates swift and cost-effective development and approval of content which is not only fully compliant with pharmaceutical compliance regulations but is technically and scientifically robust and meets client business goals.
More information: www.indigomedical.co.uk
About Waterland Private Equity
Waterland is an independent private equity firm founded in The Netherlands in 1999. Over the last 20 years, Waterland has made investments in over 600 companies across over 100 markets. Waterland manages €8 billion in funds and has teams based in the United Kingdom, Ireland, France, Netherlands, Belgium, Germany, Poland, Switzerland, and Denmark, and operates across Europe.
More information: www.waterlandpe.co.uk